24/7 Pet Web Search

Search results

1. Results From The WOW.Com Content Network

2. ELIQUIS - Pfizer

   www.pfizer.com/products/product-detail/eliquis

   ELIQUIS (apixaban) This product information is intended only for residents of the United States. for Healthcare professionals: Visit www.eliquis.com for U.S. Physician Prescribing Information

3. Apixaban - Wikipedia

   en.wikipedia.org/wiki/Apixaban

   Apixaban, sold under the brand name Eliquis, is an anticoagulant medication used to treat and prevent blood clots and to prevent stroke in people with nonvalvular atrial fibrillation through directly inhibiting factor Xa.

4. FDA approves first generics of Eliquis | FDA - U.S. Food andDrug...

   www.fda.gov/news-events/press-announcements/fda-approves-first-generics-eliquis

   The FDA granted approval of the generic apixaban applications to Micro Labs Limited and Mylan Pharmaceuticals Inc. Please contact the manufacturers for information about the medicine’s...

5. First generics to Bristol-Myers and Pfizer's Eliquis are here....

   www.fiercepharma.com/pharma/first-generics-to-bristol-myers-and-pfizer-s...

   Blood thinner Eliquis has been a major growth driver for Bristol-Myers Squibb and partner Pfizer, as well as the overall biopharma sector. Now, though, the blockbuster earner might face some...

6. UPDATE: With Multimedia: U.S. FDA Approves ELIQUIS® (apixaban ......

   www.pfizer.com/news/press-release/press-release-detail/update_with_multimedia...

   (BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) approved ELIQUIS ® (apixaban) to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.

7. Bristol-Myers Squibb and Pfizer Announce Worldwide Collaboration...

   www.pfizer.com/news/press-release/press-release-detail/bristol_myers_squibb...

   (BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc (NYSE: PFE) today announced a worldwide collaboration to develop and commercialize apixaban, an anticoagulant discovered by Bristol-Myers Squibb being studied for the prevention and treatment of a broad range of venous and arterial thrombotic conditions. In a separate ...

8. Eliquis (apixaban) FDA Approval History - Drugs.com

   www.drugs.com/history/eliquis.html

   FDA approval history for Eliquis (apixaban) used to treat Prevention of Thromboembolism in Atrial Fibrillation, Deep Vein Thrombosis Prophylaxis after Knee Replacement Surgery, Deep Vein Thrombosis Prophylaxis after Hip Replacement Surgery. Supplied by Bristol-Myers Squibb Company and Pfizer Inc.

9. F.D.A. Approves Eliquis From Bristol and Pfizer - The New York...

   www.nytimes.com/2012/12/29/business/fda-approves-eliquis-from-bristol-and...

   The Food and Drug Administration on Friday approved Eliquis, an anticlotting drug that has been highly anticipated by cardiologists and is expected to be a blockbuster for Bristol-Myers...

10. FDA approves first generic of Bristol-Myers, Pfizer's blood...

    www.reuters.com/article/business/healthcare-pharmaceuticals/fda-approves-first...

    (Reuters) - The U.S. Food and Drug Administration said on Monday it has approved the first generic version of Bristol-Myers Squibb Co and Pfizer Inc's blood thinner Eliquis.

11. Eliquis: 7 things you should know - Drugs.com

    www.drugs.com/tips/eliquis-patient-tips

    Eliquis is a brand (trade) name for apixaban which may be given to reduce the risk of blood clots. Eliquis (apixaban) works by selectively inhibiting (blocking) the effects of factor Xa (FXa), an enzyme that plays a key role in the formation of substances that cause blood clotting. Through its action on FXa, apixaban makes blood less likely to ...